Codexis share price today

(CDXS)

Codexis share price is $5.53 & ₹468.73 as on 14 Dec 2024, 2.30 'hrs' IST

$5.53

▲

-0.1

(-1.78%)

Market is closed - opens 8 PM, 16 Dec 2024

View live Codexis share price in Dollar and Rupees. Guide to invest in Codexis from India. Also see the sentimental analysis on Indian investors investing in Codexis. Get details on the Indian mutual funds that are investing in Codexis. Get Analyst recommendations and forecasts along with all the Codexis's financials.

Codexis share price movements

$5.47
$5.77
$5.53
1.08%
Downside
Day's Volatility :5.12%
Upside
4.08%
$2.53
$6.08
$5.53
54.25%
Downside
52 Weeks Volatility :58.39%
Upside
9.05%

Codexis Returns

Period	Codexis, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	94.04%	-9.7%	0.0%
6 Months	85.57%	-3.3%	0.0%
1 Year	92.01%	4.2%	0.0%
3 Years	-82.53%	4.2%	-18.1%

Codexis Key Statistics

in dollars & INR

Previous Close	$5.63
Open	$5.59
Today's High	$5.765
Today's Low	$5.47
Market Capitalization	$472.8M
Today's Volume	$796.5K
52 Week High	$6.08
52 Week Low	$2.53
Revenue TTM	$64.4M
EBITDA	$-45.8M
Earnings Per Share (EPS)	$-0.85
Profit Margin	-96.35%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-75.31%

How to invest in Codexis from India?

It is very easy for Indian residents to invest directly in Codexis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Codexis stock in both rupees (INR) and dollars (USD). Search for Codexis or CDXS on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Codexis or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Codexis shares which would translate to 0.153 fractional shares of Codexis as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Codexis

44%

Period: Sep 14, 2024 to Dec 13, 2024. Change in 30 Days versus previous period

Search volume for Codexis on INDmoney from India has grown in the last 30 days as on Dec 14, 2024. 44% more investors are searching Codexis in the last 30 days versus the previous period.

Global Institutional Holdings in Codexis

Opaleye Management Inc
10.78%
Casdin Capital, LLC
9.95%
BlackRock Inc
8.34%
FMR Inc
5.53%
Vanguard Group Inc
5.10%
Nantahala Capital Management, LLC
3.65%

Analyst Recommendation on Codexis

Buy

84%Buy

15%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Codexis(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Codexis

What analysts predicted

Upside of 29.6%

Current:

$5.53

Target:

$7.17

Insights on Codexis

Price Movement
In the last 7 days, CDXS stock has moved up by 19.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 7.97M → 12.83M (in $), with an average increase of 37.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -22.75M → -20.64M (in $), with an average increase of 10.3% per quarter
CDXS vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 32.1% return, outperforming this stock by 113.9%

Codexis Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$60.6M	↑ 21.13%
Net Income	$-10.9M	↓ 52.7%
Net Profit Margin	-17.95%	↑ 28.02%

	FY19	Y/Y Change
Revenue	$68.5M	↑ 12.98%
Net Income	$-11.9M	↑ 9.72%
Net Profit Margin	-17.43%	↑ 0.52%

	FY20	Y/Y Change
Revenue	$69.1M	↑ 0.87%
Net Income	$-24.0M	↑ 101.17%
Net Profit Margin	-34.77%	↓ 17.34%

	FY21	Y/Y Change
Revenue	$104.8M	↑ 51.69%
Net Income	$-21.3M	↓ 11.37%
Net Profit Margin	-20.31%	↑ 14.46%

	FY22	Y/Y Change
Revenue	$138.6M	↑ 32.3%
Net Income	$-33.6M	↑ 57.86%
Net Profit Margin	-24.24%	↓ 3.93%

	FY23	Y/Y Change
Revenue	$70.1M	↓ 49.39%
Net Income	$-76.2M	↑ 126.96%
Net Profit Margin	-108.69%	↓ 84.45%

	Q2 FY23	Q/Q Change
Revenue	$21.3M	↑ 64.25%
Net Income	$-11.5M	↓ 49.05%
Net Profit Margin	-54.04%	↑ 120.18%

	Q3 FY23	Q/Q Change
Revenue	$9.3M	↓ 56.49%
Net Income	$-34.9M	↑ 202.94%
Net Profit Margin	-376.29%	↓ 322.25%

	Q4 FY23	Q/Q Change
Revenue	$26.6M	↑ 186.31%
Net Income	$-7.2M	↓ 79.4%
Net Profit Margin	-27.08%	↑ 349.21%

	Q1 FY24	Q/Q Change
Revenue	$17.1M	↓ 35.72%
Net Income	$-11.5M	↑ 59.97%
Net Profit Margin	-67.39%	↓ 40.31%

	Q2 FY24	Q/Q Change
Revenue	$8.0M	↓ 53.27%
Net Income	$-22.8M	↑ 97.78%
Net Profit Margin	-285.19%	↓ 217.8%

	Q3 FY24	Q/Q Change
Revenue	$12.8M	↑ 60.83%
Net Income	$-20.6M	↓ 9.29%
Net Profit Margin	-160.84%	↑ 124.35%

	FY18	Y/Y Change
Profit	$48.0M	↑ 34.39%

	FY19	Y/Y Change
Profit	$52.8M	↑ 10.11%

	FY20	Y/Y Change
Profit	$55.3M	↑ 4.71%

	FY21	Y/Y Change
Profit	$82.5M	↑ 49.23%

	FY22	Y/Y Change
Profit	$100.6M	↑ 21.82%

	FY23	Y/Y Change
Profit	$57.3M	↓ 42.98%

	Q2 FY23	Q/Q Change
Profit	$18.1M	↑ 114.45%

	Q3 FY23	Q/Q Change
Profit	$7.0M	↓ 61.27%

	Q4 FY23	Q/Q Change
Profit	$22.5M	↑ 219.91%

	Q1 FY24	Q/Q Change
Profit	$11.0M	↓ 51.23%

	Q2 FY24	Q/Q Change
Profit	$3.3M	↓ 70.11%

	Q3 FY24	Q/Q Change
Profit	$8.5M	↑ 159.79%

	FY18	Y/Y Change
Operating Cash Flow	$-14.1M	↑ 60.84%
Investing Cash Flow	$-2.8M	↑ 204.63%
Financing Cash Flow	$38.6M	↑ 78.15%

	FY19	Y/Y Change
Operating Cash Flow	$-12.6M	↓ 10.88%
Investing Cash Flow	$-3.7M	↑ 32.5%
Financing Cash Flow	$54.0M	↑ 39.91%

	FY20	Y/Y Change
Operating Cash Flow	$-16.5M	↑ 31.08%
Investing Cash Flow	$-5.7M	↑ 56.83%
Financing Cash Flow	$80.8M	↑ 49.75%

	FY21	Y/Y Change
Operating Cash Flow	$-14.3M	↓ 13.34%
Investing Cash Flow	$-21.4M	↑ 272.69%
Financing Cash Flow	$3.8M	↓ 95.34%

	FY22	Y/Y Change
Operating Cash Flow	$11.3M	↓ 179.09%
Investing Cash Flow	$-13.6M	↓ 36.62%
Financing Cash Flow	$-575.0K	↓ 115.26%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-16.1M	↑ 74.63%
Investing Cash Flow	$-1.6M	↓ 52.16%
Financing Cash Flow	$6.9M	↑ 412.06%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-16.3M	↑ 1.34%
Investing Cash Flow	$-1.1M	↓ 29.54%
Financing Cash Flow	$-108.0K	↓ 101.56%

Codexis Technicals Summary

Sell

Neutral

Buy

Codexis is currently in a neutral trading position according to technical analysis indicators.

Codexis Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Codexis, Inc.	47.86%	85.57%	92.01%	-82.53%	-65.15%
Regeneron Pharmaceuticals, Inc.	-6.54%	-30.04%	-14.88%	11.15%	94.49%
Biontech Se	16.24%	36.11%	17.79%	-58.06%	243.94%
Alnylam Pharmaceuticals, Inc.	-4.84%	56.03%	32.5%	28.46%	104.33%
Vertex Pharmaceuticals Incorporated	-4.18%	-2.1%	12.92%	119.64%	111.27%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Codexis, Inc.	NA	NA	-1.16	-0.69	-0.75	-0.21	NA	0.9
Regeneron Pharmaceuticals, Inc.	19.12	19.12	1.15	45.03	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.23	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Codexis, Inc.	Buy	$472.8M	-65.15%	NA	-96.35%
Regeneron Pharmaceuticals, Inc.	Buy	$84.9B	94.49%	19.12	33.61%
Biontech Se	Buy	$28.9B	243.94%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.8B	104.33%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$120.6B	111.27%	32.84	-4.51%

About Codexis

codexis, inc. is a leading protein engineering company applying innovative technologies to unlock the power of proteins™. our proprietary codeevolver® technology platform enables the rapid development and production of highly optimized proteins, custom-designed for your application. codexis’ revolutionary approach to protein engineering starts with an understanding of the desired performance specifications and optimizes a protein specifically to fit these requirements. you get precisely the protein you need for the job you want it to do. guided by proprietary artificial intelligence software and advanced high-throughput screening systems, codexis is able to efficiently generate and introduce function-driven mutations to rapidly improve a protein for its target application. since 2002, codexis’ in-house biochemists, biologists and bioinformatics experts have worked closely with our clients to advance the technologies for protein optimization and production, enabling breakthrough develop

Organization	Codexis
Employees	174
CEO	Dr. Stephen George Dilly MBBS, Ph.D.
Industry	Process Industries

Management People of Codexis

Name	Title
Dr. Stephen George Dilly MBBS, Ph.D.	President, CEO & Chairman
Mr. Kevin Norrett M.B.A., M.S.	Chief Operating Officer
Dr. Alison Moore Ph.D.	Chief Technology Officer
Ms. Georgia L. Erbez	Chief Financial Officer
Ms. Carrie McKim	Director of Investor Relations
Ms. Karen Frechou-Armijo	Senior VP & Head of Human Resources
Dr. Stefan Lutz Ph.D.	Senior Vice President of Research
Mr. John Schiffhauer	Senior Vice President of Intellectual Property

Important FAQs about investing in Codexis from India :

What is Codexis share price today?

Codexis share price today stands at $5.53, Open: $5.59 ; Previous Close: $5.63 ; High: $5.77 ; Low: $5.47 ; 52 Week High: $6.08 ; 52 Week Low: $2.53. The stock opens at $5.59, after a previous close of $5.63. The stock reached a daily high of $5.77 and a low of $5.47, with a 52-week high of $6.08 and a 52-week low of $2.53.

Can Indians buy Codexis shares?

Yes, Indians can invest in the Codexis (CDXS) from India.

With INDmoney, you can buy Codexis at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Codexis at zero transaction cost.

How can I buy Codexis shares from India?

It is very easy to buy Codexis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Codexis be purchased?

Yes, you can buy fractional shares of Codexis with INDmoney app.

What are the documents required to start investing in Codexis stocks?

To start investing in Codexis, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.